Does Probiotics Gut Health Meta-Analysis work?

The current Migaku evidence database contains 2 reusable source documents for Probiotics Gut Health Meta-Analysis. This answer focuses on strength of evidence and what the studies can or cannot prove. - The most common causes associated with LC are hepatitis C, followed by alcohol consumption, hepatitis B, and metabolic liver diseases (). [Wang Yi (2026); evidence level 1] - Research indicates that LC is associated with significant intestinal barrier dysfunction, which parallels the progression of the disease. [Wang Yi (2026); evidence level 1] - The gut microbiome and barrier dysfunction are directly involved in the pathogenesis of compensated LC, and both are associated with the frequency and severity of complications in decompensated cirrhosis, such as bacterial infections and hepatic encephalopathy (HE) (). [Wang Yi (2026); evidence level 1] - 1 2 3 4 5 6 8 Liver cirrhosis (LC) is the outcome of the long-term progression of various chronic liver diseases, characterized by persistent inflammation, and is widely prevalent worldwide (). [Wang Yi (2026); evidence level 1] - Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health concern, intricately linked to metabolic disorders such as obesity, dyslipidemia, and insulin resistance. [Zhao Y (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.